Skip to main content
logo
Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
103.87
-0.92 (-0.88%)
Jul 24, 2026, 4:00 PM EDT - Market closed

Dianthus Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.344.0712.475.656.42-
Revenue Growth
-75.81%-67.35%120.63%-11.92%--
Gross Profit
1.344.0712.475.656.42-
Operating Income
-191.29-177.93-101.86-48.17-29.71-74.69
Net Income
-173.66-162.34-84.97-43.56-28.48-71.14
Earnings Per Share
-4.13-4.20-2.55-8.45-32.57-15.01
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,111404.3275.24173.7275.49176.93
Total Debt
1.361.391.490.590.790
Net Cash (Debt)
1,110402.91273.75173.1374.7176.93
Net Cash Growth
323.89%47.18%58.12%131.76%-57.78%18.87%
Net Cash Per Share
26.6410.438.2233.6085.45202.56

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-130.29-129.06-78.18-36.86-29.07-59.53
Capital Expenditures
-0.2-0.21-0.11-0.11-0.14-1.26
Free Cash Flow
-130.49-129.27-78.29-36.97-29.21-60.8
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%-
Operating Margin
-14318.00%-4369.67%-816.87%-852.34%-462.91%-
Pretax Margin
-12994.91%-3986.67%-681.39%-770.61%-443.76%-
Profit Margin
-12998.50%-3986.67%-681.39%-770.61%-443.76%-
FCF Margin
-9766.84%-3174.68%-627.79%-654.12%-455.18%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
4250.14437.4354.4027.270.86-